Fidelis Insurance stock rating reiterated at Market Outperform by JMP

Published 14/08/2025, 10:00
Fidelis Insurance stock rating reiterated at Market Outperform by JMP

Investing.com - JMP Securities has reiterated its Market Outperform rating and $27.00 price target on Fidelis Insurance Holdings (NYSE:FIHL) following the company’s better-than-expected second-quarter 2025 results. The target represents a 55% premium to the current trading price of $17.44, though InvestingPro data indicates the stock is currently trading above its Fair Value.

The research firm believes Fidelis is well-positioned to benefit from current hard market conditions in specialty insurance and reinsurance lines, which have been described as "the best in decades" and a "generational hard market." The company has demonstrated strong momentum with 24% revenue growth over the last twelve months, reaching $2.56 billion.

JMP notes that Fidelis’ leading market position in many of its underwriting classes should position it for success in coming years, while the reinsurance market also remains strong. With a market capitalization of $1.9 billion and a solid financial health score rated as "GOOD" by InvestingPro, which offers additional insights through its comprehensive Pro Research Report, the company shows promising fundamentals.

The $27 price target represents approximately 1.0x JMP’s estimate of forward book value and about 8x 2026 estimated earnings per share.

Despite investor caution regarding Fidelis’ bifurcated balance sheet/MGU structure, JMP believes time will demonstrate aligned interests, pointing to the Fidelis Partnership receiving no profit commission as the L.A. fire losses and Russia/Ukraine aviation charge brought year-to-date underwriting returns below specified hurdles.

In other recent news, Fidelis Insurance Holdings Limited reported second-quarter earnings that missed analyst estimates. The company posted a net income of $19.7 million, or $0.18 per diluted share, significantly below the expected $0.79 per share. This shortfall was largely due to an $89.2 million net adverse prior-year loss reserve development related to the English High Court judgment in the Russia-Ukraine aviation litigation. The company’s combined ratio increased to 103.7%, up from 92.7% in the same period last year, indicating higher costs relative to its earned premiums. These developments have drawn attention to the ongoing impact of the litigation on Fidelis’s financial results.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.